Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $54.32 million. The enterprise value is -$111.64 million.

Market Cap	54.32M
Enterprise Value	-111.64M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 17.08 million shares outstanding. The number of shares has increased by 1.02% in one year.

Current Share Class	17.08M
Shares Outstanding	17.08M
Shares Change (YoY)	+1.02%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	38.34%
Float	12.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.31
P/TBV Ratio	0.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.05.

Current Ratio	7.38
Quick Ratio	7.13
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -183.89% and return on invested capital (ROIC) is -103.04%.

Return on Equity (ROE)	-183.89%
Return on Assets (ROA)	-85.30%
Return on Capital (ROIC)	-103.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.31M
Employee Count	117
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mural Oncology has paid $1.98 million in taxes.

Income Tax	1.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.22%
50-Day Moving Average	3.59
200-Day Moving Average	3.56
Relative Strength Index (RSI)	35.64
Average Volume (20 Days)	182,958

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-159.32M
Pretax Income	n/a
Net Income	-153.78M
EBITDA	-156.06M
EBIT	-159.32M
Earnings Per Share (EPS)	-$9.12

Full Income Statement

Balance Sheet

The company has $175.50 million in cash and $9.55 million in debt, giving a net cash position of $165.96 million or $9.72 per share.

Cash & Cash Equivalents	175.50M
Total Debt	9.55M
Net Cash	165.96M
Net Cash Per Share	$9.72
Equity (Book Value)	174.14M
Book Value Per Share	10.22
Working Capital	158.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$139.50 million and capital expenditures -$1.25 million, giving a free cash flow of -$140.75 million.

Operating Cash Flow	-139.50M
Capital Expenditures	-1.25M
Free Cash Flow	-140.75M
FCF Per Share	-$8.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.02%
Shareholder Yield	-1.02%
Earnings Yield	-283.12%
FCF Yield	-259.13%

Analyst Forecast

The average price target for Mural Oncology is $16.00, which is 403.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	403.15%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-51.43%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2